| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Funder | Competition | Research | Implementation/Clinical Care | KX/ Travel | Education | Open to projects outside of Canada? | Lead must be based in Canada? | Key words | Due date | Max value | Currency | Length (months) | Website | ||||||||||||
2 | Horizon Europe - EDCTP3 | Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence | Y | Y | N | N | Y | N | Should contribute to strengthening clinical human capital base in R&I, enhancing talent retention, knowledge sharing of best practices within the research and innovation landscape, accelerate integration of digital tools into health systems, expand and scale up validated innovations with tangible implementation at national and/or sub-regional levels. | September 2, 2026 | 15,000,000 - 18,000,000 | EUR | https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02?keywords=HORIZON-JU-GH-EDCTP3-2026&isExactMatch=true&status=31094501,31094502,31094503&order=DESC&pageNumber=1&pageSize=50&sortBy=startDate | |||||||||||||
3 | Gates Foundation | Multiplex Platforms to Assess Indicators of Micronutrient Status, Inflammation and Infectious Disease | Y | N | N | N | Y | N | This Grand Challenge seeks novel approaches to extend analytical coverage, improve sensitivity and specificity, simplify measurement, reduce cost, and enable frequent monitoring of micronutrient status by local institutions. Open to nonprofit organizations, for-profit companies, international organizations, government agencies and academic institutions. | September 8, 2026 | 200,000 - 800,000 | USD | 12 - 24 | https://gcgh.grandchallenges.org/challenge/multiplex-platforms-assess-indicators-micronutrient-status-and-infection-and-inflammation | ||||||||||||
4 | TDR & WHO AFRO | 2026-2027 Joint WHO African Region/TDR Impact Grants for Implementation Research for Regional Priorities | Y | Y | N | N | Y | N | This initiative aims to strengthen health research capacity in developing countries and support implementation research that can help deliver high-quality, cost-efficient health care solutions to people living in resource-poor settings. PI and majority of research team must be based in the African region. | September 15, 2026 | 15,000 | USD | 12 | https://who.my.site.com/etdr/s/gs-solicitation/a0pVj000007eS3DIAU/ca260033 | ||||||||||||
5 | Science Granting Councils Initiative in sub-Saharan Africa (SGCI) | Supporting STISA 2034: SGCI Multilateral Research Call advancing Africa’s Science, Technology and Innovation priorities | Y | N | N | N | Y | N | Funds collaborative, multi-country research projects that advance Africa’s science, technology and innovation priorities and contribute to sustainable development outcomes across the continent. The call supports research aligned with five thematic streams: Agriculture, Health, Artificial intelligence and Digital technologies, Energy, Environment. Applications must be submitted by a consortium consisting of one lead applicant organization and two to four co-applicant organizations from participating SGCI countries. | September 25, 2026 | 50,000 - 300,000 per consortium member | CAD | 36 | https://idrc-crdi.ca/en/funding/supporting-stisa-2034-sgci-multilateral-research-call-advancing-africas-science-technology?utm_source=Funding+Alerts&utm_campaign=9d4dd71633-EMAIL_CAMPAIGN_7_31_2020_9_57_COPY_01&utm_medium=email&utm_term=0_02f2dae0ce-9d4dd71633-481119737 | ||||||||||||
6 | Gates Foundation | Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows | Y | N | N | N | Y | N | This RFP aims to accelerate the development of affordable, scalable, and operationally simple sequencing solutions, enabling routine use of genomics for public health in low- and middle-income countries (LMICs). Projects and/or consortia applications led by applicants from LMICs encouraged. | September 29, 2026 | 300,000 - 800,000 | USD | 24 - 36 | https://gcgh.grandchallenges.org/challenge/innovations-low-cost-and-simplified-pathogen-sequencing-workflows | ||||||||||||
7 | CEPI | Innovations to Prepare for Future Epidemics and Pandemics | Y | N | N | N | Y | N | For (1) innovative vaccine platforms that can transform outbreak response to Disease X, addressing needs for speed, safety/efficacy, and access; or (2) advance new vaccine candidates for CEPI priority pathogens and viral families. | Rolling until 2026 | 5,000,000 | USD | 36 - 60 | https://cepi.net/calls-for-proposals?selectedProposal=9bde4615-b7b1-5f00-a079-a3080e88a845&selectedProposal=c08cff7c-f002-506a-8afb-cc2e921056ae | ||||||||||||
8 | Health Research BC | Match Funding | Y | N | N | N | N | Y | Applying to peer-reviewed, non-BC-government-funded research competition that requires match funding; Link to human health; Must be used in BC | 5 weeks before competition deadline | https://healthresearchbc.ca/match-funding/ | |||||||||||||||
9 | Addax & Oryx Foundation | N/A | N | Y | N | N | Y | N | Low success rate (1%); Root causes of poverty; Africa and Middle East; Non-profit/NGO-led; Local community involvement; Holistic (Health, education, community development, environment) | Rolling | https://addax-oryx-foundation.org/en/submit-a-project | |||||||||||||||
10 | Humanitarian Grand Challenge | Transition to Scale | Y | N | N | N | Y | N | Humanitarian crises; Health supplies and equipment; WASH; Access to data; Energy | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
11 | Grand Challenges Canada | Transition to Scale | Y | Y | N | N | Y | N | Scaling innovations in Maternal and Newborn Health, Digital Health, Medical Products and Technology, Community Health Worker Models, Urban Sanitation & Hygiene, and Options for safe pregnancy termination; Requires match-funding' SSA-led | Rolling | 3,000,000 | CAD | https://www.grandchallenges.ca/funding-opportunities/ | |||||||||||||
12 | Roncalli International Foundation | Grant | N | Y | N | Y | Y | Y | Requires Canadian organization to receive funds, but partnership with implementing community | Rolling | 35,000 | CAD | 12 | https://roncalli.ca/en/grant-application/eligibility-criteria/ | ||||||||||||
13 | Nestle Foundation | Pilot Grants | Y | N | N | Y | Y | N | LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
14 | Nestle Foundation | Small Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 50,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
15 | Nestle Foundation | Large Research Grants | Y | N | N | Y | Y | N | LMIC-based; Usually after Pilot Grant; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 300,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
16 | Nestle Foundation | Training Grant | Y | N | N | Y | Y | N | MSc or PhD Student; LMIC-based; Clinical research in nutrition; Public health relevance; Potetential for implementation; Nutrition education/health promotion | Rolling | 20,000 | USD | 24 | https://www.nestlefoundation.org/apply.html | ||||||||||||
17 | Nestle Foundation | Re-entry Grants | Y | N | N | N | Y | N | LMIC-based; Supports return to home country; Needs support from host institution | Rolling | 50,000 | USD | 36 | https://www.nestlefoundation.org/apply.html | ||||||||||||
18 | Commonweath Fund | Project Grants | Y | Y | N | N | Y | N | Primarily US-focused; Global priorities include: models of effective primary care, policy solutions to improve health care affordability , and partners with access to data sets to complete international comparisons of access, cost, and quality of care. Clinical, policy, or implementation research | Rolling | 180,000 | USD | 12 | https://www.commonwealthfund.org/grants | ||||||||||||
19 | Fonds d'Innovation pour le Developpement | Preperation Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; For preparing for pilot or preperation for scaling grant | Rolling | 50,000 | EUR | 6 | https://fundinnovation.dev/en/launch-project | ||||||||||||
20 | Fonds d'Innovation pour le Developpement | Pilot Grant | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Testing innovations in real-world environment | Rolling | 200,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
21 | Fonds d'Innovation pour le Developpement | Test and Preparation for Scaling Up | Y | N | N | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; ; Testing for impact on larger scale and evaluating cost-effectiveness | Rolling | 1,500,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
22 | Fonds d'Innovation pour le Developpement | Scaling Up | Y | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; aims to pilot, test and evaluate the impact of projects using rigorous scientific methods; Implementation following rigorous evidence of impact and cost-effectiveness | Rolling | 4,000,000 | EUR | 36 | https://fundinnovation.dev/en/launch-project | ||||||||||||
23 | Fonds d'Innovation pour le Developpement | Transformatiom of Public Policies | N | N | Y | N | Y | N | Funds must go to LMICs; Apply as an organization, not individual; Institutionalizing innovations or building capacity of governements to design, test, and evalution innovations | Rolling | 500,000 | EUR | 24 | https://fundinnovation.dev/en/launch-project | ||||||||||||
24 | Founders Pledge | Global Health and Development Fund | N | Y | N | N | Y | N | Implementation, not research. Global health and development programs, especially programs that can, in expectation, save a life for under $4,000, avert a DALY for under $70, or double income for one person at a cost of less than $30. Note that this includes interventions that affect economic growth. We don’t necessarily require that grantees be able to point to an RCT in order to demonstrate cost-effectiveness | Rolling | 300,000 | USD | https://www.founderspledge.com/requests-for-funding | |||||||||||||
25 | Open Philanthropy | Grants - Global Health and Wellbeing: Scientific Research | Y | N | N | N | Y | N | Current topics of interest include road-spectrum antiviral drugs, vaccine development, basic immunology, some aspects of cardiovascular disease, Alzheimer’s disease, predicting mouse-to-human translation, control of inflammation, epigenetics, novel scientific tools and methods, malaria, and research on how biomedical research may be improved. | Rolling | 50,000 - 2,600,000 | USD | https://www.openphilanthropy.org/focus/scientific-research/ | |||||||||||||
26 | ||||||||||||||||||||||||||
27 | ||||||||||||||||||||||||||
28 | ||||||||||||||||||||||||||
29 | ||||||||||||||||||||||||||
30 | ||||||||||||||||||||||||||
31 | ||||||||||||||||||||||||||
32 | ||||||||||||||||||||||||||
33 | ||||||||||||||||||||||||||
34 | ||||||||||||||||||||||||||
35 | ||||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||
38 | ||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||
40 | ||||||||||||||||||||||||||
41 | ||||||||||||||||||||||||||
42 | ||||||||||||||||||||||||||
43 | ||||||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||
46 | ||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||
48 | ||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||
50 | ||||||||||||||||||||||||||
51 | ||||||||||||||||||||||||||
52 | ||||||||||||||||||||||||||
53 | ||||||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |